The report assesses Hematopoietic Stem Cell
Transplantation therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
This article summarizes the hospital infection control guidelines in the Guidelines for Preventing Opportunistic Infections Among Hematopoietic Stem Cell
Transplant Recipients, with ratings in brackets.
The initial focus of ASC is to transform clinical efficacy outcomes for hematopoietic stem cell
transplantation with ASC-101.
Three donor/patient pairs showed that CDX-301 given as a single agent for 5 days was well tolerated and effective at mobilizing hematopoietic stem cells
in healthy donors.
CLDX) presented new clinical data on CDX-301(recombinant human Flt3 ligand), an hematopoietic cytokine that expands dendritic cells and hematopoietic stem cells
FCRx is a novel allogeneic hematopoietic stem cell
based therapy platform that also contains facilitating cells derived from a donor.
Genzyme Corporation, Cambridge, MA, announced the US Food and Drug Administration (FDA) has granted marketing approval for Mozobil (plerixafor injection), a drug intended to be used in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells
to the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM).
International Conference and Workshop on Hematopoietic Stem Cells
(6th: 2006: Tubingen, Germany) Ed.
Keio University's COE is using the unique microfluidic properties of the Fluidigm's integrated fluidic circuits (IFCs) to analyze selected genes in hematopoietic stem cells
About 3,000 children require hematopoietic stem cell
transplantation each year in the United States.
As described in the patent, Pluristem's therapeutic cells are designed to promote the success of hematopoietic stem cell
transplantation, which is used to treat patients with dysfunctional bone marrow.
professor and director of the Hematopoietic Stem Cell
Laboratory, University of Pittsburgh Cancer Institute, isolated the vascular cells from human fat tissue and expanded the cells by growing them in a specialized blood-culturing medium for 21 to 42 days.